⌕
HUTCHMED (China) · HCM · Nasdaq
Tenet 49 · Mixed
Compare
$14.90+0.34%At closeTenet 49 · Mixed
$14.90+0.05 (+0.34%)
At close: Nov 13, 2026, 4:00 PM ET· Nasdaq · USD

HUTCHMED (China) (HCM) Stock

HUTCHMED (China) (HCM) closed at $14.90 on Nov 13, 2026; its Tenet Score is 49 of 100 against 409 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

15 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$14.90
Nov 13, 2026
Market cap
$2.6Bunverified basis
share basis not confirmed
P/E
5.7×
price ÷ earnings
52-week range
9.77 – 16.33
low → high
Tenet Score
49/100
Mixed · 409 Healthcare peers

Industry: Drugs · see every company filed here →

HUTCHMED (China) Limited scores 49/100. Mixed. Strongest on financial health, quality is the soft spot, trading at 6× earnings versus 409 Healthcare peers. Insufficient inputs: Tenet 49 is built from 3 of 4 pillars, from 40% of its inputs. The pillars showing a dash had no data.

Tenet Score · vs sector

n=409
49/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
—
Quality
33
Health
66
Growth
49

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
Value omitted — no data yet.
Value—QualityDHealthCGrowthDMomentumD
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
2.1×
price to book value
P/S
4.7×
price to sales
ROE
45%
return on equity
Operating margin
−7.1%
before interest and tax
Net margin
—
units_artifact
Current ratio
4.96
current assets to liabilities
Net debt / EBITDA
—
no_ebitda
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

Market cap: share price × the latest quarter's diluted weighted-average share count (vendor).

The whole report, at a glance · every card is a live peek, click any to open the section

About HUTCHMED (China) Limited

HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company dev…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=409) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 4 US ETFs · top wrappers by weightSee all ETFs holding HCM →

What sector and industry is HUTCHMED (China) in?

HUTCHMED (China) is in the Healthcare sector and the Drugs industry.

What is HUTCHMED (China)'s Tenet Score?

HUTCHMED (China)'s Tenet Score is 49 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.